Feedback mechanisms between T helper cells and macrophages in the determination of the immune response

Mathematical Biosciences

Volumn 163, Issue 1, 2000, Pages 35-58

  Lev Bar Or, Ruth ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cytokines; Feedback loops; Macrophages; Mathematical model; Th1 Th2

Indexed keywords

ANTIGEN PRESENTING CELL; ARTICLE; CELL INTERACTION; CELL KILLING; CYTOKINE RELEASE; EFFECTOR CELL; FEEDBACK SYSTEM; HELPER CELL; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MATHEMATICAL MODEL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CYTOKINES; FEEDBACK; HUMANS; MACROPHAGES; MICE; MODELS, IMMUNOLOGICAL; SARCOIDOSIS; TH1 CELLS; TH2 CELLS; TRICHINELLA SPIRALIS; TRICHINOSIS;

EID: 0343384369     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(99)00046-2     Document Type: Article

References (84)

1. Mosmman T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 7:1989;145.
2. Scott P. Selective differentiation of CD4+ T helper cell subsets. Curr. Opin. Immunol. 5:1993;391.
3. Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell. 76(2):1994;241.
4. T.R. Mosmann, K.W. Moore, in: C. Ash, R.B. Gallagher (Eds.), Immunoparasitology Today, Elsevier, Cambridge, 1991, p. A49.
5. G. Trinchieri, The two faces of interleukin 12: a pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells, in: D. Chadwick, G. Cardew (Eds.), T Cell Subsets in Infectious and Autoimmune Diseases, Ciba Foundation Symposium 195. Wiley, Chichester, 1995, p. 203.
6. Coffman R.L., Lebman D.A., Rothman P. Mechanisms and regulation of immunoglobin isotype switching. Adv. Immunol. 54:1993;229.
7. Firestein G.S., Roeder W.D., Laxer J.A.et al. A new murine CD4+ T cell subset with an unrestricted cytokine profile. J. Immunol. 143:1989;518.
8. Street N.E., Schumacher J.H., Fong T.A.et al. Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J. Immunol. 144:1990;1629.
9. Kelso A., Glasebrook A.L. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones. J. Immunol. 132:1984;2924.
10. Ferrick D.A., Schrenzel M.D., Mulvania T., Hsieh B., Ferlin W.G., Lepper H. Differential production of interferon γ and interleukin 4 in response to Th1 and Th2-stimulating pathogens by γδ T cells in vivo. Nature. 373:1995;255.
11. Sad S., Marcotte R., Mosmann T.R. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ cells secreting Th1 or Th2 cytokines. Immunity. 2:1995;271.
12. Fong T.A.T., Mosmann T.R. Alloreactive murine CD8+ T cell clones secrete the TH1 pattern of cytokines. J. Immunol. 144:1990;1744.
13. Seder R.A., Boulay J.-L., Finkelman F.et al. CD8+ T cells can be primed in vitro to produce IL-4. J. Immunol. 148:1992;1652.
14. Erard F., Wild M.T., Garcia-Sanz J.A., Le Gros G. Switch of CD8+ T cells to non-cytolytic CD8-CD4-cells that make Th2 cytokines and help B cells. Science. 260:1993;1802.
15. Croft M., Carter L., Swain S.L., Dutton R.W. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin IL-4 and IL-12 in promoting Type 2 versus Type 1 cytokine profiles. J. Exp. Med. 180:1994;1715.
16. Maggi E., Giudizi M.G., Biagotti R., Annunziato F.et al. Th2-like CD8+ T cells showing B cell helper function and reduced cytolitic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180:1994;489.
17. D.M. Paulnock, The molecular biology of macrophage activation, in: B.S. Zwilling, T.K. Eisensyein (Eds.), Macrophage-Pathogen Interactions, Marcel Dekker, New York, 1994, p. 47.
18. Fishman M.A., Perelson A.S. Th1/Th2 crossregulation. J. Theor. Biol. 170:1994;25.
19. Carneiro J., Stewart J., Coutinho A., Countinho G. The ontogeny of class-regulation of CD4+ T lymphocyte populations. Int. Immunol. 7(8):1995;1265.
20. Muraille E., Leo O., Kaufman M. The role of antigen presentation in the regulation of class-specific (Th1/Th2) immune responses. J. Biol. Syst. 3(2):1995;397.
21. Morel B.F., Burke M., Kalagnanam J., McCarthy S.A., Tweardy D.J., Morel P. Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical model. Bull. Math. Biol. 58(3):1996;569.
22. Lev Bar-Or R., Segel L.A. On the role of a possible dialog between cytokine and TCR-presentation mechanisms in the regulation of autoimmune diseases. J. Theor. Biol. 190:1998;161.
23. Croft M., Dubey C. Accessory molecule and costimulation requirements for CD4 T cell response. Crit. Rev. Immunol. 17:1997;89.
24. Taylor-Robinson A.W., Phillips R.S., Severn A., Moncada S., Liew F.W. The role of Th1 and Th2 cells in a rodent malaria infection. Science. 260:1993;1931.
25. Von der Weid T., Langhorne J. The roles of cytokines produced in the immune response to the erythrocytic stages of mouse malarias. Immunobiology. 189:1993;397.
26. Ruuls S.R., Van der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467.
27. Willenborg D.O., Fordham S., Benard C.C.A.et al. IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:1996;3223.
28. A.K. Abbas, V.L. Perez, L. van Parijs, R.C. Wong, R.C.K., Differentiation and tolerance of CD4+ T lymphocytes. in: D. Chadwick, G. Cardew, (Eds.), T Cell Subsets in Infectious and Autoimmune Diseases, Ciba Foundation Symposium 195, Wiley, Chichester, 1995, p. 7.
29. R.L. Coffman, R. Correa-Oliviera, S. Mocci, Reversal of polarized T helper 1 and T helper 2 cell populations in murine leishmaniasis, in: D. Chadwick, G. Cardew (Eds.), T Cell Subsets in Infectious and Autoimmune Diseases, Ciba Foundation Symposium 195, Wiley, Chichester, 1995, p. 20.
30. Murphy E., Shibuya K., Hosken N.et al. Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J. Exp. Med. 183:1996;901.
31. R.M. Crawford, D.A. Leiby, S.J. Green, C.A. Nacy, A.H. Fortier, M.S. Meltzer, Macrophage activation: a riddle of immunological resistance, in: B.S. Zwilling, T.K. Eisensyein (Eds.), Macrophage-Pathogen Interactions, Marcel Dekker, New York, 1994, p. 29.
32. Nabors G.S., Nolan T., Croop W.L.et al. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune response in (BALB/C × C57 BL/6) F.1 mice infected with leishmania major. Parasite Immunol. 17:1995;569.
33. Baumer I., Zissel G., Schlaak M., Muller-Quernheim J. Th1/Th2 cell distribution in pulmonary sarcoidosis. Am. J. Respir. Cell Mol. Biol. 16:1997;171.
34. Fultz M.J., Barber S.A., Dieffenbach C.W., Vogel S.N. Induction of IFN-γ in macrophages by lipopolysaccharide. Int. Immunol. 5:1993;1383.
35. F.Y. Liew, Nitric oxide in infectious and autoimmune diseases, in: D. Chadwick, G. Cardew (Eds.), T Cell Subsets in Infectious and Autoimmune Diseases, Ciba Foundation Symposium 195, Wiley, Chichester, 1995, p. 234.
36. Gazinelli R.T., Oswald I.P., James S.L., Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148:1992;1792.
37. T.R. Mosmann, Interleukin-10, in: A. Thomson (Ed.), The Cytokine Handbook, Academic Press, London, 1994, p. 223.
38. K.J. Tracey, Tumour necrosis factor-alpha, in: A. Thomson (Ed.), The Cytokine Handbook, Academic Press, London, 1994, p. 289.
39. Metcalf D. The Colony Stimulating Factors. 1984;Elsevier, Amsterdam.
40. Brown M.A., Hural J. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17:1997;1.
41. Howard M., O'Garra A. Biological properties of interleukin. Immunol. Today. 13:1992;198.
42. R. Derynck, Transforming growth factor-beta, in: A. Thomson (Ed.), The Cytokine Handbook, Academic Press, London, 1994, p. 319.
43. Maeda H., Shiraishi A. TGF-contributes to the shift toward Th2-type responses through direct and I-mediated pathways in tumor-bearing mice. J. Immunol. 156:1996;73.
44. A.W. Thomson, M.T. Lotze, Interleukins 13, 14 and 15, in: A. Thomson (Ed.), The Cytokine Handbook, Academic Press, London, 1994, p. 257.
45. S.A. Safley, H.K. Ziegler, Antigen processing and presentation, in: B.S. Zwilling, T.K. Eisensyein (Eds.), Macrophage-Pathogen Interactions, Marcel Dekker, New York, 1994, p. 115.
46. Sztein M.B., Steeg P.S., Johnson H.M, Oppenheim J.J Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J. Clin. Invest. 73:1984;556.
47. Cerami A. Inflammatory cytokines. Clin. Immunol. Immunopath. 62:1992;S3.
48. Gasson J.C. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood. 77:1991;1131.
49. Zlotnick A., Fisher M., Roehm N., Zipori D. Evidence for effects of interleukin-4 (Bcell stimulatory factor-1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages. J. Immunol. 138:1987;4275.
50. McKenzie A.N.J., Culpepper J.A., de Waal Maleyft R., Briere F.et al. Interleukin 13, a T-cell derived cytokine that regulates human monocyte and B-cell function. Proc. Nat. Acad. Sci. USA. 90:1993;3735.
51. DeWaal Malefyt R., Haanen J., Spits H., Roncarolo M.et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:1991;915.
52. Srimal S., Nathan C. Purification of macrophage deactivating factor. J. Exp. Med. 171:1990;1347.
53. H. Zeh III, H. Tahara, M.T. Lotze, Interleukin-10, in: A. Thomson (Ed.), The Cytokine Handbook, Academic Press, London, 1994, p. 239.
54. Marshall J.D., Sercrist H., DeKruyff R., Wolf S.F., Umentsu D.T. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J. Immunol. 155:1995;111.
55. Tsung K., Meko J.B., Peplinski G.R., Tsung Y.L., Norton J.A. IL-12 induces T-helper 1-directed antitumor response. J. Immunol. 158(7):1997;3359.
56. Ushio S., Namba M., Okura T.et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biological activities of the protein. J. Immunol. 156:1996;4274.
57. Kunkel S.L., Spengler M., May M.A., Spengler R., Larrick J., Remick D. Prostanglandin E2 regulates macrophages-derived tumor necrosis factor gene expression. J. Immunol. 263:1988;5380.
58. van der Kraan Pouw T.C.T.M., Boeije L.C.M., Smeenk R.J.T., Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin production. J. Exp. Med. 181:1995;775.
59. Kalinski P., Hilkens C.M.U., Snijders A., Snijdewint F.G.M., Kaapsenberg M.L. IL-12 deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J. Immunol. 159:1997;28.
60. S.K. Durum, Future cytokines: interleukin 2001, in: A. Thomson (Ed.), The Cytokine Handbook, Academic Press, London, 1994, p. 595.
61. Carter L., Dutton R. Type-1 and Type-2: a fundamental dichotomy for all T cell subsets. Curr. Opin. Immunol. 8:1996;336.
62. De Boer R.J., Perelson A.S. Towards a general function describing T cell proliferation. J. Theor. Biol. 175:1995;567.
63. C.L. Manthey, S.N. Vogel, Interactions of Lypopolysaccharide with macrophages, in: B.S. Zwilling, T.K. Eisensyein (Eds.), Macrophage-Pathogen Interactions, Marcel Dekker, New York, 1994, p. 63.
64. R. Lev Bar-Or, Theoretical consideration of effector choice in immunology, PhD thesis (1998).
65. Rook G.A.W, Hernandez Pando R. T cell helper types and endocrines in the regulation of tissue-damaging mechanisms in tuberculosis. Immunobiology. 191:1994;484.
66. McHugh S.M., Rifkin I.R., Deighton J., Wilson A.B., Lachmann P.J., Lockwood C.M., Ewan P.W. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin. Exp. Immunol. 99:1995;160.
67. Barnard A., Mahon B.P., Watkins J., Redhead K., Mills K.H.G. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1 Th2 or Th0. Immunology. 87:1996;372.
68. Gerosa F., Peritt D., Paganin C., Paiola F., Scupoli M.T., Aste-Amezagga M., Frank I., Trinchieri G. Interleukin-12 primes human CD4 and CD8 T cells clones for high production of both interferon-gamma and interleukin-10. J. Exp. Med. 183(6):1996;2559.
69. Murray H.W., Hariprashad J., McDermott D.F., Stoeckle M. Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral leishmania donovani infection. Infect. Immunol. 64(1):1996;161.
70. Okura Y., Yamamoto T., Goto S.et al. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J. Molec. Cell. Cardiol. 29:1997;491.
71. Rook G.A.W., Steele J., Ainsworth M., Champion B.R. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology. 59:1986;333.
72. Fishman M.A., Segel L.A. Modeling immunotherapy for allergy. Bull. Math. Biol. 58(6):1996;1099.
73. Becky Kelly E.A., Cruz E.S., Hauda K.M., Wassom D. IFN-γ and IL-5-producing cells compartmentalize to different lymphoid organs in Trinchiella spiralis - infected mice. J. Immunol. 147:1991;306.
74. A. Schaffner, T. Schaffner, Glucocorticoid-induced impairment of macrophage antimicrobial activity: mechanisms and dependence on the state of activation, Rev. Infect. Dis 9 (Suppl 5) (1987) S620.
75. Duijvestijn A., Hamann A. Mechanisms and regulation of lymphocyte migration. Immunol. Today. 10:1989;23.
76. Black C.M., Catterall J.R., Remington J.S. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-γ J. Immunol. 138:1987;491.
77. Fortier A.H., Polsinelli T., Green S.J., Nacy C.A. Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect Immunol. 60:1992;817.
78. C.C. Stewart, M.C. Riedy, S.J. Stewart, Introduction: the proliferation and differentiation of macrophages, in: B.S. Zwilling, T.K. Eisensyein (Eds.), Macrophage-Pathogen interactions, Marcel Dekker, New York, 1994, p. 3.
79. Georhiou H.M., Constantinou D., Mandel T.H. Prevention of autoimmunity in nonobese diabetic (NOD) mice by neonatal transfer of allogeneic thymic macrophages. Autoimmunity. 21:1995;89.
80. R.G. Titus, C.M. Theodos, A.H. Shankar, L.R. Hall, Interactions between Leishmania major and macrophages, in: B.S. Zwilling, T.K. Eisensyein (Eds.), Macrophage-Pathogen Interactions, Marcel Dekker, New York, 1994, p. 437.
81. J.L. Krahenbuhl, L.B. Adams, The role of macrophage in resistance to the leprosy bacillus, in: B.S. Zwilling, T.K. Eisensyein (Eds.), Macrophage-Pathogen Interactions, Marcel Dekker, New York, 1994, p. 281.
82. L.A. Segel, R. Lev Bar-Or, On the role of feedback in promoting conflicting goals of the adaptive immune system, J. Immunol. 163 (1999) 1342.
83. Rissoan M.C.et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 283:1999;1183.
84. K. Bottomly, T cells and dendritic cells get intimate, Science 283 (1999) 1124.